Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus

Brain Research

Volumn 814, Issue 1-2, 1998, Pages 1-12

  Kimes, Alane S ^a   Maldonado, Rafael ^b   Ambrosio, Emilio ^c   Koob, George F ^d   London, Edythe D ^a  

^a Brain Imaging Section   (United States)

^b INSERM   (France)

^c UNIVERSIDAD A DISTANCIA DE MADRID   (Spain)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Central amygdala; Cerebral glucose metabolism; Intracerebral injections; Locus coeruleus; Methylnaloxonium; Opiate withdrawal; Opioid abstinence; Opioid withdrawal; Rat

Indexed keywords

17 METHYLNALOXONE; NALOXONE; OPIATE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROPHYSIOLOGY; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE REGULATION; BRAIN; FUNCTIONAL LATERALITY; GLUCOSE; HEART RATE; INJECTIONS; LOCUS COERULEUS; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, INBRED F344; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032517840     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00813-0     Document Type: Article

References (49)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J.Neurosci. 11:1991;3830-3839.
3. Akaoka H., Aston-Jones G. Indirect serotonergic agonists attenuate neuronal opiate withdrawal. Neuroscience. 54:1993;561-565.
4. Baumeister A.A., Richard A.L., Richmond-Landeche L., Hurry M.J., Waguespack A.M. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome. Neuropharmacology. 31:1992;835-841.
5. Bell J.A., Jaffe J.H. Electrophysiological evidence for a presynaptic mechanism of morphine withdrawal in the neonatal rat spinal cord. Brain Res. 382:1986;299-304.
6. Bell J.A., Kimes A.S., London E.D. Increased glucose utilization in superficial layers of the rat spinal dorsal horn during precipitated morphine withdrawal. Eur. J. Pharmacol. 150:1988;171-174.
7. Britton K.T., Svensson T., Schwartz J., Bloom F.E., Koob G.F. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34:1984;133-139.
8. Cohen S.R., Kimes A.S., London E.D. Morphine decreases cerebral glucose utilization in limbic and forebrain regions while pain has no effect. Neuropharmacology. 30:1991;125-134.
9. Crossland J., Ahmed K.Z. Brain acetylcholine during morphine withdrawal. Neurochem. Res. 9:1984;351-366.
10. Dam M., London E.D. Glucose utilization in the Papez circuit: Effects of oxotremorine and scopolamine. Brain Res. 295:1984;137-144.
11. Dam M., Wamsley J.K., Rapoport S.I., London E.D. Effect of oxotremorine on local glucose utilization in the rat cerebral cortex. J. Neurosci. 2:1982;1072-1078.
12. Delfs J.M., Druhan J.P., Aston-Jones G. Involvement of non-locus coeruleus (LC) projections to forebrain in the expression of opiate withdrawal-induced conditioned place aversion (CPA). Soc. Neurosci. Abstr. 23:1997;1108-1108. Abstract.
13. della Puppa A., Kimes A.S., London E.D. Dose-dependent effects of D-N-allylnormetazocine on regional cerebral metabolic rates for glucose. Brain Res. 603:1993;38-46.
14. Domesick V.B. Thalamic relationships of the medial cortex in the rat. Brain Behav. Evol. 6:1972;457-483.
15. Dow-Edwards D., Dam M., Peterson J.M., Rapoport S.I., London E.D. Effect of oxotremorine on local cerebral glucose utilization in motor system regions of the rat brain. Brain Res. 226:1981;281-289.
16. Franz D.N., Hare B.D., McCloskey K.L. Spinal sympathetic neurons: Possible sites of opiate-withdrawal suppression by clonidine. Science. 215:1982;1643-1645.
17. Gold M.S., Redmond D.E., Kleber H.D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. II(8089):1978;599-602.
18. Guitart X., Kogan J.H., Berhow M., Terwilliger R.Z., Aghajanian G.K., Nestler E.J. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Res. 611:1993;7-17.
19. Guitart X., Nestler E.J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: Studies in the rat locus coeruleus. Neurochem. Res. 18:1993;5-13.
20. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus-coeruleus. J. Neurochem. 58:1992;1168-1171.
21. Harris G.C., Aston-Jones G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature. 371:1994;155-157.
22. Ivanov A., Aston-Jones G. Local opiate withdrawal in locus coeruleus (LC) neurons recorded intracellularly in vitro. Soc. Neurosci. Abstr. 23:1997;125-125. Abstract.
23. Jhamandas K., Sutak M. Modification of brain acetylcholine release by morphine and its antagonists in normal and morphine-dependent rats. Br. J. Pharmacol. 50:1974;57-62.
24. Kimes A.S., Bell J.A., London E.D. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal. Neuroscience. 34:1990;633-644.
25. Kimes A.S., London E.D. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal. J. Pharmacol. Exp. Ther. 248:1989;538-545.
26. Kimes A.S., Raymon L.P., Meltzer L.T., Heffner T., London E.D. Cerebral metabolic effects of CI-943 (8-ethyl-7,8-dihydro-1,3,5-trimethyl-1H-imadazo[1,2,-c]pyrazolo[3,4-e] pyrimidine), a potential antipsychotic drug. Drug Dev. Res. 24:1991;29-39.
27. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
28. Krystal J.H., Compere S., Nestler E.J., Rasmussen K. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats. Physiol. Behav. 59:1996;863-866.
29. Lagowska J., Calvino B., Ben-Ari Y. Intra-amygdaloid applications of naloxone elicits severe withdrawal signs in morphine dependent rats. Neurosci. Lett. 8:1978;241-245.
30. Lindvall O., Björklund A. The organization of the ascending catecholamine neuron systems in the rat brain: As revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. 412:1974;1-48.
31. London E.D., Connolly R.J., Szikszay M., Wamsley J.K., Dam M. Effects of nicotine on local cerebral glucose utilization in the rat. J. Neurosci. 8:1988;3920-3928.
32. London E.D., Fanelli R.J., Kimes A.S., Moses R.L. Effects of chronic nicotine on cerebral glucose utilization in the rat. Brain Res. 520:1990;208-214.
33. S.E. Loughlin, J.H. Fallon, Locus coeruleus, in: G. Paxinos (Ed.), The Rat Nervous System, Vol. 2, Academic Press, Orlando, FL, 1985, pp. 79-93.
34. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
35. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
36. R.D. Myers, Handbook of Drug and Chemical Stimulation of the Brain. Behavioral, Pharmacological and Physiological Aspects, Van Nostrand Reinhold-New York, 1974.
37. Nestler E.J., Alreja M., Aghajanian G.K. Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus. Brain Res. Bull. 35:1994;521-528.
38. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Orlando, FL, 1986.
39. Rada P., Pothos E., Mark G.P., Hoebel B.G. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res. 561:1991;354-356.
40. Satoh K., Fibiger H.C. Cholinergic neurons of the laterodorsal tegmental nucleus: Efferent and afferent connections. J. Comp. Neurol. 253:1986;277-302.
41. Schroeder R.L., Weinger M.B., Vakassian L., Koob G.F. Methylnaloxonium diffuses out of the rat brain more slowly than naloxone after direct intracerebral injection. Neurosci. Lett. 121:1991;173-177.
42. Serafin M., Khateb A., Mühlethaler M. Opiates inhibit pedunculopontine neurones in guinea pig brainstem slices. Neurosci. Lett. 119:1990;125-128.
43. 14C ]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat J. Neurochem. 28:1977;897-916.
44. Stinus L., Le Moal M., Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience. 37:1990;767-773.
45. Stinus L., Peron A., Reneric J.P., Cador M., Koob G.F. In morphine dependent rats, the total lesion of locus coeruleus norepinephrine neurons does not impair naloxone-induced withdrawal syndrome and conditioned-place aversion, or the protective effects of clonidine upon opiate withdrawal. Soc. Neurosci. Abstr. 23:1997;1108-1108. Abstract.
46. Theriault E., Otsuka M., Jessell T. Capsaicin-evoked release of substance P from primary sensory neurons. Brain Res. 170:1979;209-213.
47. Tremblay E.C., Charton G. Anatomical correlates of morphine-withdrawal syndrome: Differential participation of structures located within the limbic system and striatum. Neurosci. Lett. 23:1981;137-142.
48. Wei E., Loh H.H., Way E.L. Brain sites of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 185:1973;108-115.
49. Wei E., Sigel S.S.R., Loh H.H., Way E.L. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat. J. Pharmacol. Exp. Ther. 195:1975;480-487.